Evidence map›Paper›PMID 28881594›Full record

ArticleOncotarget2017

The miR-106a~363

Daniel A Kuppers, Thomas M Schmitt, Harry C Hwang, Lavanya Samraj, Bruce E Clurman, Matthew L Fero

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. MicroRNAs in Autoimmunity and Hematological Malignancies.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daniel A KuppersFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Thomas M SchmittFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Harry C HwangPhenopath Laboratories, Seattle, Washington, USA.
Lavanya SamrajUniversity of Washington, Seattle, Washington, USA.
Bruce E ClurmanFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Matthew L FeroUniversity of New Mexico, Albuquerque, New Mexico, USA.
Fred Hutch Cancer Center · USUniversity of New Mexico · USUniversity of Washington · US

Funding

Cell Autonomy and Tumor Suppression by CDK inhibitorsR01CA100053 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FERO, MATTHEW L · 2005 to 2009
$1.7M
NCI NIH HHS R01 CA100053
6 · The paper itself

Abstract

The miR-106a~363 cluster encodes 6 miRNAs on the X-chromosome which are abundant in blood cells and overexpressed in a variety of malignancies. The constituent miRNA of miR-106a~363 have functional activities

Indexed as

cell cyclemouse modelnon-coding RNAoncogeneT cell development

Identifiers

PMID28881594
PMCPMC5584189
OpenAlexW2604708474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.